Strength: knee flexor and extensor strength · participants with haemophilia
1 finding from 1 review
Reduction in pain intensity · participants with haemophilia
1 finding from 1 review
Range of Motion: flexion and extension · participants with haemophilia
1 finding from 1 review
Perinatal death or severe morbidity · pregnant women with confirmed or suspected chorioamnionitis
The review found no eligible studies for this question.
1 finding from 1 review
Maintenance of initial therapeutic response of at least 30% pain intensity reduction over baseline and continued treatment at 13 or 26 weeks (equivalent to 'moderate benefit') · adults with fibromyalgia enrolled in EERW studies
1 finding from 1 review
Hypertensive disorders of pregnancy · women with gestational diabetes mellitus
1 finding from 1 review
Intervention not reported
Change in pain intensity from baseline 100 mm VAS · people with chronic low back pain
1 finding from 1 review
Intervention not reported
Sensitivity analysis: change in pain intensity from baseline 100 mm VAS · people with chronic low back pain
1 finding from 1 review
Change in pain intensity from baseline on VAS (0 to 100) short‐term · people with low back pain with sciatica
It is very uncertain whether NSAIDs changes change in pain intensity from baseline on VAS (0 to 100) short‐term compared with placebo (very low certainty).
1 finding from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether topical treatments (lactoperoxidase oral rinse / Biotene) changes relief of burning/discomfort (symptom relief; pain intensity) compared with placebo (very low certainty).
1 finding from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months) · hypericum perforatum
Hypericum perforatum extract (Sardella 2008, the only low-risk-of-bias study) contributes to the dietary supplements short-term symptom-relief comparison (insufficient/contradictory); no separate estimate reported.
1 study · 43 participants
GRADE not reported
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Dose/intensity and frequency of pain relief needed (analgesic/rescue medication use) · Adolescents/teenagers undergoing orthodontic treatment
1 finding from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether dietary supplements (alpha lipoic acid +/- vitamins) changes relief of burning/discomfort (symptom relief; pain intensity) compared with placebo (very low certainty).
1 finding from 1 review
Relief of burning/discomfort (symptom relief; pain intensity) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
1 finding from 1 review
Interventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months) · gabapentin with adjunctive ALA
SoF2 subgroup. Gabapentin + adjunctive ALA vs placebo forms one of two subgroups of the anticonvulsant symptom-relief estimate (RR 4.00, 2.09 to 7.67); no between-subgroup difference vs gabapentin alone; 100…
1 study · 40 participants
Very low
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · patients with rheumatoid arthritis
1 finding from 1 review
Improvement More than 1 category change in pain intensity on 4‐point scale (no pain/sporadic/daily/continuous) · patients with rheumatoid arthritis
Additional radon in carbon dioxide baths showed no clear difference in improvement More than 1 category change in pain intensity on 4‐point… compared with carbon dioxide baths only (low certainty).
2 findings from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · patients with rheumatoid arthritis
1 finding from 1 review
Pain intensity VAS (0 to 100; 0 = no pain, 100 = worst pain) · patients with rheumatoid arthritis
2 findings from 1 review
Hypertensive disorders of pregnancy (including pre‐eclampsia) · Pregnant women at low risk of complications
Reduced number of antenatal care visits/goal‐oriented showed no clear difference in hypertensive disorders of pregnancy (including pre‐eclampsia) compared with standard antenatal care visits (low certainty).
1 finding from 1 review